Cargando…

Immune thrombocytopenia (ITP) World Impact Survey (I‐WISh): Impact of ITP on health‐related quality of life

Immune thrombocytopenia (ITP) has a substantial, multifaceted impact on patients' health‐related quality of life (HRQoL). Data describing which aspects of ITP physicians and patients perceive as having the greatest impact are limited. The ITP World Impact Survey (I‐WISh) was a cross‐sectional s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cooper, Nichola, Kruse, Alexandra, Kruse, Caroline, Watson, Shirley, Morgan, Mervyn, Provan, Drew, Ghanima, Waleed, Arnold, Donald M., Tomiyama, Yoshiaki, Santoro, Cristina, Michel, Marc, Laborde, Serge, Lovrencic, Barbara, Hou, Ming, Bailey, Tom, Taylor‐Stokes, Gavin, Haenig, Jens, Bussel, James B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898815/ https://www.ncbi.nlm.nih.gov/pubmed/33107998 http://dx.doi.org/10.1002/ajh.26036

Ejemplares similares

Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment
por: Cooper, Nichola, et al.
Publicado: (2020)

P1589: PATIENT (PT) AND PHYSICIAN (MD) PERCEPTIONS OF THE BURDEN OF IMMUNE THROMBOCYTOPENIA (ITP) AND ITS MANAGEMENT: RESULTS FROM THE ITP WORLD IMPACT SURVEY (I-WISH) 2.0
por: Cooper, Nichola, et al.
Publicado: (2023)

Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia
por: Viana, Ricardo, et al.
Publicado: (2021)

Immune Thrombocytopenia (ITP): Current Limitations in Patient Management
por: Terrell, Deirdra R., et al.
Publicado: (2020)

How do patients and physicians perceive immune thrombocytopenia (ITP) as a disease? Results from Indian analysis of ITP World Impact Survey (I-WISh)
por: Chakrabarti, Prantar, et al.
Publicado: (2022)

PB2608: THE MANAGEMENT OF IMMUNE THROMBOCYTOPENIA (ITP) IN NORWAY IN THE REAL LIFE – ANALYSIS OF THE NOR-ITP REGISTRY
por: Ilicheva, Ekaterina, et al.
Publicado: (2023)

Proposal for a New Protocol for the Management of Immune Thrombocytopenia (ITP)
por: González-López, Tomás José, et al.
Publicado: (2022)

Overuse of corticosteroids in patients with immune thrombocytopenia (ITP) between 2011 and 2017 in the United States
por: Cuker, Adam, et al.
Publicado: (2023)

PB2619: THE IMPACT OF ITP-DIRECTED TREATMENT ON FATIGUE AMONG CHILDREN AND ADOLESCENTS WITH CHRONIC ITP: DATA FROM THE ITP NATURAL HISTORY STUDY REGISTRY
por: Diraimo, Jennifer, et al.
Publicado: (2023)

Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP Registry
por: Doobaree, Indraraj Umesh, et al.
Publicado: (2019)

SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP
por: Lee, Eun-Ju, et al.
Publicado: (2022)

Do Splenectomized Immune Thrombocytopenia (ITP) Patients Have Increased Risks for Platelet Decreases Following COVID-19 Vaccination?
por: MacWhirter - DiRaimo, Jennifer, et al.
Publicado: (2021)

Avatrombopag for the Treatment of Adult Patients with Chronic Immune Thrombocytopenia (cITP): Focus on Patient Selection and Perspectives
por: Tsykunova, Galina, et al.
Publicado: (2022)

COVID-19 Vaccination in Adults with Immune Thrombocytopenia (ITP): Data from the Platelet Disorder Support Association (PDSA) Patient Registry
por: MacWhirter - DiRaimo, Jennifer, et al.
Publicado: (2021)

Patient and Physician Perspectives in the Management of Immune Thrombocytopenia in Iran: Responses from the ITP World Impact Survey (I-WISh)
por: Eshghi, Peyman, et al.
Publicado: (2023)

Immune Thrombocytopenia (ITP) Secondary to Subclinical Hashimoto’s Thyroiditis: Role of Levothyroxine in Improving the Clinical Outcome of ITP
por: Tahir, Hassan, et al.
Publicado: (2016)

Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP
por: Jawed, Muzamil, et al.
Publicado: (2021)

Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)
por: Zufferey, Anne, et al.
Publicado: (2017)

The 4 T's of ITP: Tailoring Therapies to Treat Thrombocytopenia
por: Hughes, David
Publicado: (2022)

Japanese and French translation and linguistic validation of a patient-reported outcome tool to assess quality of life in patients with Immune Thrombocytopenia (ITP): the ITP Life Quality Index (ILQI)
por: Tomiyama, Yoshiaki, et al.
Publicado: (2022)

PB2620: NIGHTTIME SYMPTOMS ARE ASSOCIATED WITH FATIGUE AMONG CHILDREN AND ADOLESCENTS WITH CHRONIC ITP: DATA FROM THE ITP NATURAL HISTORY STUDY REGISTRY
por: Diraimo, Jennifer, et al.
Publicado: (2023)

COVID-19 Vaccination in Children and Young Adults with Pre-Existing Immune Thrombocytopenia (ITP): Preliminary Data from the Platelet Disorder Support Association (PDSA) Patient Registry
por: MacWhirter - DiRaimo, Jennifer, et al.
Publicado: (2022)

An ITP workbook
por: Kalman, J A
Publicado: (1986)

Response to rituximab in children and adults with immune thrombocytopenia (ITP)
por: Harris, Emily M., et al.
Publicado: (2021)

Management of Adult Patients with Primary Immune Thrombocytopenia (ITP) in Clinical Practice: A Consensus Approach of the Spanish ITP Expert Group
por: Mingot-Castellano, M. Eva, et al.
Publicado: (2019)

Secondary immune thrombocytopenia (ITP) as an initial presentation of Whipple’s disease
por: Priest, David H., et al.
Publicado: (2017)

ITP Conference on High T
por: Collective
Publicado: (2000)

Lenalidomide-Associated ITP
por: Herold, Christina I., et al.
Publicado: (2011)

Long-Term Use of the Thrombopoietin-Mimetic Romiplostim in Children With Severe Chronic Immune Thrombocytopenia (ITP)
por: Bussel, James B, et al.
Publicado: (2015)

The Role of Leptin in Childhood Immune Thrombocytopenia (ITP): An Anti-Inflammatory Agent?
por: Thomas, Iason, et al.
Publicado: (2021)

Assessment and Management of Immune Thrombocytopenia (ITP) in the Emergency Department: Current Perspectives
por: Zitek, Tony, et al.
Publicado: (2022)

Reticulated Platelet Count as a Diagnostic Tool in Immune Thrombocytopenia (ITP)
por: Butt, Aqsa Javed, et al.
Publicado: (2023)

P1637: RISKS FOR A PLATELET COUNT DROP: COVID-19 & ITP DATA FROM THE PLATELET DISORDER SUPPORT ASSOCIATION (PDSA) PATIENT REGISTRY
por: DiRaimo, J., et al.
Publicado: (2022)

The automated reasoning system ITP
por: Lusk, E L, et al.
Publicado: (1984)

Rituximab resistance in ITP and beyond
por: Xiao, Zhengrui, et al.
Publicado: (2023)

P1638: EARLY USE OF ELTROMBOPAG IN ADULT PATIENTS WITH ITP WHO ARE REFRACTORY OR RELAPSED AFTER FIRST-LINE CORTICOSTEROID THERAPY – AN AD HOC ANALYSIS OF THE TAPER TRIAL RESULTS
por: Ghanima, W., et al.
Publicado: (2022)

P1606: PRIMARY AND SECONDARY IMMUNE THROMBOCYTOPENIA (ITP) IN ADULTS: REAL WORLD COMPARATIVE RETROSPECTIVE STUDY FROM THE ITP REGISTRY OF THE HELLENIC SOCIETY OF HEMATOLOGY
por: Stavroulaki, Emily, et al.
Publicado: (2023)

A Narrative Approach to Describe QoL in Children With Chronic ITP
por: Giordano, Paola, et al.
Publicado: (2019)

The Impact of Ethnicity on the Response to Eltrombopag in Patients With Immune Thrombocytopenia (ITP) in Qatar: A Single Institution Experience
por: Yassin, Mohamed A, et al.
Publicado: (2022)

Severe Immune Thrombocytopenia (ITP) Following SARS-CoV-2 mRNA Vaccine in a Girl on Immunosuppressive Treatment and in Prolonged Stable Phase of ITP
por: Bianchi, Simona, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_beeh5g1osushl4mmvqrhul9p25